Oric Pharmaceuticals (ORIC) Shares Issued (2019 - 2026)

Oric Pharmaceuticals' Shares Issued history runs 8 years deep, the most recent figure standing at $9.4 million for Q1 2026.

• Quarterly Shares Issued rose 35.58% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 35.58% YoY) and the FY2025 annual result came in at $13.9 million, up 23.58% from the prior year.
• Shares Issued was $9.4 million for Q1 2026 at Oric Pharmaceuticals, down from $13.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $14.2 million in Q2 2025 and bottomed at $1.7 million in Q3 2022.
• A 5-year average of $7.8 million and a median of $8.7 million in 2023 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2022 — Shares Issued tumbled 68.26% — and 2024, when it soared 516.04%.
• Oric Pharmaceuticals' Shares Issued stood at $6.7 million in 2022, then soared by 30.27% to $8.7 million in 2023, then climbed by 29.07% to $11.2 million in 2024, then increased by 23.58% to $13.9 million in 2025, then slumped by 32.07% to $9.4 million in 2026.
• Business Quant data shows ORIC's Shares Issued at $9.4 million in Q1 2026, $13.9 million in Q4 2025, and $14.1 million in Q3 2025.